Dr. Craig William Spenner Sr., MD

Dr. Spenner practices at Healthmark Ballas LLC in Saint Louis, Missouri.

Dr. Spenner's NPI, 1154320877, was assigned on July 14, 2005. Dr. Spenner graduated from Saint Louis University School of Medicine in 1977. Dr. Spenner holds Missouri license R1A88.

Dr. Spenner's primary practice is Healthmark Ballas LLC, at 456 N New Ballas Rd, Saint Louis, MO 63141 in Saint Louis County. The practice phone is (314) 373-7000.

Dr. Spenner's primary practice is Healthmark Ballas LLC in Saint Louis, Missouri. The medical group on file is Premier Dermatology. Dmand AI also links Dr. Spenner to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Spenner practices. Vendor and product names are available with a free account.

Dermatology is Dr. Spenner's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Spenner is board certified in dermatology by the American Board of Dermatology. Dr. Spenner is licensed in Missouri.

CMS data shows 1,931 Medicare services from Dr. Spenner across 10 procedure codes in 2024, for 354 Medicare patients. Medicare paid $74,792 for them. Every service was in an office.

CMS counts 354 Medicare patients who saw Dr. Spenner in 2024. The largest group is 65 to 74, with 151 patients. 75% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 0.94, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Spenner's median patient age at 71, with 50% women.

In 2024, Dr. Spenner wrote 372 Medicare Part D claims for 181 patients. 94% of them were for generic drugs. CMS names the drug for 251 of them, across 10 drugs with 11 or more claims each, at $6,511 in total drug cost. In 2023, CMS named 192 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 0 out of 100 for Dr. Spenner for performance year 2024, reported individually. Dr. Spenner accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 748 procedures of removal of skin lesions by Dr. Spenner, more than 90% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 663 general payments to Dr. Spenner from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $1,550.

Dr. Spenner graduated from Saint Louis University School of Medicine in 1977.